CME Group Inc. (NASDAQ:CME) Shares Purchased by MGO One Seven LLC

MGO One Seven LLC lifted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 16.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,881 shares of the financial services provider's stock after acquiring an additional 994 shares during the quarter. MGO One Seven LLC's holdings in CME Group were worth $1,598,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Lake Street Advisors Group LLC increased its holdings in CME Group by 108.7% during the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock valued at $2,949,000 after buying an additional 6,453 shares during the period. Meyer Handelman Co. bought a new position in shares of CME Group in the 4th quarter worth $6,144,000. Unified Investment Management purchased a new stake in shares of CME Group during the 4th quarter worth $503,000. Spire Wealth Management boosted its position in CME Group by 37.4% during the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock valued at $307,000 after purchasing an additional 359 shares in the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc grew its stake in CME Group by 19.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider's stock valued at $75,730,000 after purchasing an additional 52,862 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently commented on CME. Piper Sandler boosted their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a research note on Monday, March 10th. Oppenheimer boosted their price target on CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research note on Friday, April 11th. Bank of America increased their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Finally, Barclays boosted their target price on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $256.80.

Insider Activity at CME Group

In other CME Group news, Director Larry G. Gerdes sold 2,000 shares of CME Group stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the sale, the director now owns 38,651 shares in the company, valued at $10,207,729.10. The trade was a 4.92 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company's stock, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 29,076 shares of company stock valued at $7,399,696. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

CME traded up $1.62 on Monday, reaching $267.92. 1,778,531 shares of the company's stock were exchanged, compared to its average volume of 2,156,143. The stock has a market cap of $96.55 billion, a PE ratio of 27.71, a P/E/G ratio of 6.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $273.42. The stock's fifty day moving average price is $258.77 and its 200-day moving average price is $242.09.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The firm's revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the business posted $2.50 earnings per share. Sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.87%. This is a positive change from CME Group's previous quarterly dividend of $1.15. CME Group's dividend payout ratio is currently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.